ENFIERA RITUXIMAB INJECTION

Get a Price/Quote

ENFIERA RITUXIMAB INJECTION Specification

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Biological

Dosage Form
Injection

Indication
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

Salt Composition
Rituximab

Drug Type
Allopathic

Ingredients
Rituximab

Physical Form
Liquid Injection

Function
Anti-cancer, Monoclonal antibody

Recommended For
Cancer, Non-Hodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis

Dosage
As directed by physician

Dosage Guidelines
Administered via intravenous infusion under medical supervision

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store at 2C to 8C. Do not freeze.

ENFIERA RITUXIMAB INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About ENFIERA RITUXIMAB INJECTION

Enfiera Injection

Specifications:-

Strength:Available in 500 mg & 100 mg
Form:Injection
Packaging Size:1 vial of 50 ml
Manufacturer:Zydus
Composition:Rituximab
Brand:ENFIERA

Note :- ENFIERA Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Precise Targeted Therapy for Cancer and Autoimmunity

ENFIERA Rituximab is a monoclonal antibody designed to precisely target certain immune cells, making it highly effective in treating cancers like non-Hodgkins lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases such as rheumatoid arthritis. Its method of action disrupts disease progression while minimizing damage to healthy cells, offering patients a focused and reliable treatment option.

Safe Administration Under Medical Supervision

This injection must be administered intravenously by healthcare professionals in a controlled setting to ensure patient safety. Dosage and infusion schedules are individualized according to your physicians instructions, optimizing therapeutic effect and minimizing risks. The product is strictly prescription-based, and contraindications, such as hypersensitivity to rituximab or its components, must always be evaluated.

Optimal Storage and Handling Instructions

ENFIERA Rituximab features a shelf life of 24 months when stored in a refrigerated environment between 2C and 8C. Freezing the product is strictly prohibited as it can compromise its efficacy and safety. Healthcare providers and distributors are advised to adhere to these guidelines to ensure the integrity of the medication from shipment to administration.

FAQs of ENFIERA RITUXIMAB INJECTION:

Q: How should ENFIERA Rituximab Injection be administered?

A: ENFIERA Rituximab Injection is administered intravenously as an infusion by trained healthcare professionals in a medical facility. It is never given as an injection at home or by untrained individuals.

Q: What are the main indications for using this medication?

A: This medication is recommended for adults diagnosed with non-Hodgkins lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis, as prescribed by a physician.

Q: When should ENFIERA Rituximab not be used?

A: ENFIERA Rituximab should not be used in individuals who are hypersensitive to rituximab or any of its excipients. Always disclose any allergies to your healthcare provider before starting treatment.

Q: Where should ENFIERA Rituximab Injection be stored?

A: The vial must be stored refrigerated between 2C and 8C, and never frozen. Storage guidelines help maintain the medications efficacy and safety until its 24-month shelf period concludes.

Q: What is the process for obtaining ENFIERA Rituximab?

A: ENFIERA Rituximab can be obtained through prescription only from healthcare facilities, distributors, exporters, suppliers, traders, or wholesalers in India. A registered medical practitioner must evaluate your eligibility and provide a prescription.

Q: What are the benefits of using ENFIERA Rituximab Injection?

A: Patients may benefit from targeted therapy that helps slow or stop disease progression in certain cancers and autoimmune disorders, often with fewer side effects compared to traditional chemotherapy.

Q: How is the dosage of ENFIERA Rituximab determined?

A: The dosage and frequency are determined by your physician based on your specific condition, medical history, and treatment progression. It is crucial to follow professional medical advice strictly for optimal results.

Tell us about your requirement